IFF (IFF) is introducing PureStrong, a new probiotic developed exclusively for canine digestive health. “PureStrong is sourced directly from the microbiome of healthy canines and designed to support how dogs actually live-how they eat, travel, age and adapt to change,” said Allyson Fish, senior vice president of health sciences for IFF. “That’s how IFF leads pet wellness: science-driven innovation that performs in the real world.”
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IFF:
- IFF secures heart health claim for soy protein in Australia, New Zealand
- The Week That Was, The Week Ahead: Macro and Markets, Mar. 15
- IFF to transform Arroyito site into enzyme production hub
- IFF price target raised to $100 from $95 at Citi
- Icahn boosts stakes in Centuri and Monro, reduces stake in International Flavors